<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Complete Guide to kappasizepower: Power Analysis for Inter-rater Agreement Studies • meddecide</title>
<script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet">
<link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet">
<script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Complete Guide to kappasizepower: Power Analysis for Inter-rater Agreement Studies">
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top bg-light" data-bs-theme="light" aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">meddecide</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.0.32.01</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item"><a class="nav-link" href="../reference/index.html">Reference</a></li>
<li class="active nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-articles" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Articles</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-articles">
<li><a class="dropdown-item" href="../articles/01-introduction.html">MedDecide 01: Introduction to Medical Decision Analysis for Pathologists</a></li>
    <li><a class="dropdown-item" href="../articles/02-comprehensive-guide.html">meddecide: Medical Decision Making in R</a></li>
    <li><a class="dropdown-item" href="../articles/03-agreement-advanced-features.html">Advanced Features in Interrater Agreement Analysis</a></li>
    <li><a class="dropdown-item" href="../articles/03-agreement-analysis.html">Inter-Rater Agreement and Reliability Analysis in Pathology</a></li>
    <li><a class="dropdown-item" href="../articles/03-roc-analysis.html">ROC Curve Analysis</a></li>
    <li><a class="dropdown-item" href="../articles/04-decision-tree-guide.html">Medical Decision Tree - Clinical Implementation Guide</a></li>
    <li><a class="dropdown-item" href="../articles/05-decision-tree-analysis.html">Decision Tree Graph Analysis: Comprehensive Guide and Testing</a></li>
    <li><a class="dropdown-item" href="../articles/06-decision-tree-vs-markov.html">Decision Tree vs Markov Chain Analysis: Complete Guide</a></li>
    <li><a class="dropdown-item" href="../articles/06-jamovi-workflow-examples.html">Jamovi Workflow Examples for Decision Tree and Markov Analysis</a></li>
    <li><a class="dropdown-item" href="../articles/07-bayesian-decision-curve-analysis.html">Bayesian Decision Curve Analysis - Advanced Clinical Decision Making</a></li>
    <li><a class="dropdown-item" href="../articles/07-decision-trees.html">Decision Tree and Markov Chain Analysis Examples</a></li>
    <li><a class="dropdown-item" href="../articles/07-kappasizeci-comprehensive.html">Sample Size Calculations for Interobserver Agreement Studies</a></li>
    <li><a class="dropdown-item" href="../articles/08-decision-panel-clinical.html">Clinical Applications of Decision Panel Optimization</a></li>
    <li><a class="dropdown-item" href="../articles/08-kappasizefixedn-comprehensive.html">Complete Guide to kappasizefixedn: Fixed Sample Size Kappa Power Analysis</a></li>
    <li><a class="dropdown-item" href="../articles/09-decision-panel-advanced.html">Advanced Features and Customization in Decision Panel Optimization</a></li>
    <li><a class="dropdown-item" href="../articles/09-kappasizepower-comprehensive.html">Complete Guide to kappasizepower: Power Analysis for Inter-rater Agreement Studies</a></li>
    <li><a class="dropdown-item" href="../articles/10-decision-panel-optimization.html">Introduction to Decision Panel Optimization</a></li>
    <li><a class="dropdown-item" href="../articles/11-precision-oncology.html">Precision Oncology: Biomarker-Guided Treatment Selection and Outcome Analysis</a></li>
    <li><a class="dropdown-item" href="../articles/12-nogoldstandard.html">Analyzing Diagnostic Tests without a Gold Standard</a></li>
    <li><a class="dropdown-item" href="../articles/13-diagnostic-tests.html">Diagnostic Test Evaluation</a></li>
    <li><a class="dropdown-item" href="../articles/14-diagnostic-style-quick-guide.html">Quick Guide: Diagnostic Style Clustering in jamovi</a></li>
    <li><a class="dropdown-item" href="../articles/15-diagnostic-style-clustering.html">Diagnostic Style Clustering: Identifying Pathologist 'Schools' and Diagnostic Preferences</a></li>
    <li><a class="dropdown-item" href="../articles/16-use-in-r.html">Use meddecide in R</a></li>
    <li><a class="dropdown-item" href="../articles/17-introduction-legacy.html">meddecide: Introduction to Medical Decision Analysis</a></li>
    <li><a class="dropdown-item" href="../articles/18-roc-analysis-legacy.html">ROC Curve Analysis</a></li>
    <li><a class="dropdown-item" href="../articles/19-decisionpanel-advanced-legacy.html">Advanced Features and Customization in Decision Panel Optimization</a></li>
    <li><a class="dropdown-item" href="../articles/20-decisionpanel-clinical-legacy.html">Clinical Applications of Decision Panel Optimization</a></li>
    <li><a class="dropdown-item" href="../articles/21-decisionpanel-optimization-legacy.html">Introduction to Decision Panel Optimization</a></li>
    <li><a class="dropdown-item" href="../articles/22-diagnostic-style-clustering-legacy.html">Diagnostic Style Clustering: Identifying Pathologist 'Schools' and Diagnostic Preferences</a></li>
    <li><a class="dropdown-item" href="../articles/23-diagnostic-style-quick-guide-legacy.html">Quick Guide: Diagnostic Style Clustering in jamovi</a></li>
    <li><a class="dropdown-item" href="../articles/24-agreement-analysis-legacy.html">Inter-Rater Agreement and Reliability Analysis in Pathology</a></li>
    <li><a class="dropdown-item" href="../articles/25-diagnostic-tests-legacy.html">Diagnostic Test Evaluation</a></li>
    <li><a class="dropdown-item" href="../articles/25-jamovi-workflow-examples-legacy.html">Jamovi Workflow Examples for Decision Tree and Markov Analysis</a></li>
    <li><a class="dropdown-item" href="../articles/26-medical-decision-tree-guide-legacy.html">Medical Decision Tree - Clinical Implementation Guide</a></li>
    <li><a class="dropdown-item" href="../articles/27-nogoldstandard-legacy.html">Analyzing Diagnostic Tests without a Gold Standard</a></li>
    <li><a class="dropdown-item" href="../articles/28-decision-tree-examples-legacy.html">Decision Tree and Markov Chain Analysis Examples</a></li>
    <li><a class="dropdown-item" href="../articles/29-decision-tree-vs-markov-analysis-legacy.html">Decision Tree vs Markov Chain Analysis: Complete Guide</a></li>
    <li><a class="dropdown-item" href="../articles/30-decisiontree-analysis-vignette-legacy.html">Decision Tree Graph Analysis: Comprehensive Guide and Testing</a></li>
    <li><a class="dropdown-item" href="../articles/31-precision-oncology-biomarkers-legacy.html">Precision Oncology: Biomarker-Guided Treatment Selection and Outcome Analysis</a></li>
    <li><a class="dropdown-item" href="../articles/32-vignettes-legacy.html">meddecide: Medical Decision Making in R</a></li>
    <li><a class="dropdown-item" href="../articles/33-use-in-r-legacy.html">Use meddecide in R</a></li>
    <li><a class="dropdown-item" href="../articles/34-cotest-analysis.html">Co-Testing Analysis: Combining Diagnostic Tests for Better Clinical Decision Making</a></li>
    <li><a class="dropdown-item" href="../articles/35-screening-calculator-comprehensive.html">Screening Test Calculator: A Comprehensive Guide</a></li>
    <li><a class="dropdown-item" href="../articles/36-sequential-testing-comprehensive.html">Sequential Testing Analysis: A Comprehensive Guide</a></li>
    <li><a class="dropdown-item" href="../articles/38-modelbuilder-comprehensive.html">Clinical Prediction Model Builder</a></li>
    <li><a class="dropdown-item" href="../articles/decisionpanel_threshold_calculator.html">Decision Panel Threshold Calculator (p_t)</a></li>
    <li><a class="dropdown-item" href="../articles/meddecide-01-oncodatasets-examples.html">meddecide: Medical Decision Analysis with Oncology Data</a></li>
    <li><a class="dropdown-item" href="../articles/meddecide-05-decisiongraph-comprehensive.html">Decision Tree Analysis with decisiongraph: A Comprehensive Guide</a></li>
    <li><a class="dropdown-item" href="../articles/meddecide-09-digital-pathology-validation.html">Digital Pathology Validation: Agreement Analysis and Modality Comparison</a></li>
    <li><a class="dropdown-item" href="../articles/meddecide-15-multiclass-diagnostics-comprehensive.html">Multi-class Diagnostic Performance Evaluation</a></li>
  </ul>
</li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">Changelog</a></li>
      </ul>
<ul class="navbar-nav">
<li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json">
</form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/sbalci/ClinicoPathJamoviModule/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
      </ul>
</div>


  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>Complete Guide to kappasizepower: Power Analysis for Inter-rater Agreement Studies</h1>
                        <h4 data-toc-skip class="author">ClinicoPath
Development Team</h4>
            
            <h4 data-toc-skip class="date">2025-10-09</h4>
      
      <small class="dont-index">Source: <a href="https://github.com/sbalci/ClinicoPathJamoviModule/blob/HEAD/vignettes/09-kappasizepower-comprehensive.Rmd" class="external-link"><code>vignettes/09-kappasizepower-comprehensive.Rmd</code></a></small>
      <div class="d-none name"><code>09-kappasizepower-comprehensive.Rmd</code></div>
    </div>

    
    
<div class="section level2">
<h2 id="introduction">Introduction<a class="anchor" aria-label="anchor" href="#introduction"></a>
</h2>
<p>The <code>kappasizepower</code> function provides <strong>power
analysis for sample size determination</strong> in inter-rater agreement
studies. Unlike fixed sample size analysis, this function answers the
question: <em>“How many subjects do I need to detect a meaningful
improvement in agreement between raters?”</em></p>
<div class="section level3">
<h3 id="when-to-use-kappasizepower">When to Use kappasizepower<a class="anchor" aria-label="anchor" href="#when-to-use-kappasizepower"></a>
</h3>
<p>This function is essential for research scenarios where:</p>
<ul>
<li>
<strong>Designing new agreement studies</strong> with specific power
requirements</li>
<li>
<strong>Validating training programs</strong> that aim to improve
inter-rater agreement</li>
<li>
<strong>Standardizing clinical protocols</strong> requiring
demonstrated agreement improvements</li>
<li>
<strong>Grant applications</strong> requiring rigorous power
analysis justification</li>
<li>
<strong>Multi-center studies</strong> establishing minimum
recruitment targets</li>
</ul>
</div>
<div class="section level3">
<h3 id="key-concepts">Key Concepts<a class="anchor" aria-label="anchor" href="#key-concepts"></a>
</h3>
<div class="section level4">
<h4 id="power-analysis-framework">Power Analysis Framework<a class="anchor" aria-label="anchor" href="#power-analysis-framework"></a>
</h4>
<p>Traditional power analysis determines sample size based on:
<strong>Effect Size + Power + Alpha → Sample Size</strong></p>
<p>For kappa agreement: <strong>κ₁ - κ₀ + Power + Alpha → Required
N</strong></p>
</div>
<div class="section level4">
<h4 id="hypothesis-testing-for-agreement">Hypothesis Testing for Agreement<a class="anchor" aria-label="anchor" href="#hypothesis-testing-for-agreement"></a>
</h4>
<ul>
<li>
<strong>H₀</strong>: κ = κ₀ (null hypothesis agreement level)</li>
<li>
<strong>H₁</strong>: κ = κ₁ (alternative hypothesis agreement
level)</li>
<li>
<strong>Effect Size</strong>: κ₁ - κ₀ (improvement in
agreement)</li>
</ul>
</div>
<div class="section level4">
<h4 id="critical-validation">Critical Validation<a class="anchor" aria-label="anchor" href="#critical-validation"></a>
</h4>
<p><strong>κ₁ must be greater than κ₀</strong> - The alternative
hypothesis should represent better agreement than the null
hypothesis.</p>
</div>
</div>
</div>
<div class="section level2">
<h2 id="theoretical-background">Theoretical Background<a class="anchor" aria-label="anchor" href="#theoretical-background"></a>
</h2>
<div class="section level3">
<h3 id="inter-rater-agreement-fundamentals">Inter-rater Agreement Fundamentals<a class="anchor" aria-label="anchor" href="#inter-rater-agreement-fundamentals"></a>
</h3>
<p>Cohen’s kappa (κ) measures agreement beyond chance:</p>
<p><math display="block" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>κ</mi><mo>=</mo><mfrac><mrow><msub><mi>p</mi><mi>o</mi></msub><mo>−</mo><msub><mi>p</mi><mi>e</mi></msub></mrow><mrow><mn>1</mn><mo>−</mo><msub><mi>p</mi><mi>e</mi></msub></mrow></mfrac></mrow><annotation encoding="application/x-tex">\kappa = \frac{p_o - p_e}{1 - p_e}</annotation></semantics></math></p>
<p>Where: -
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>p</mi><mi>o</mi></msub><annotation encoding="application/x-tex">p_o</annotation></semantics></math>
= observed agreement -
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>p</mi><mi>e</mi></msub><annotation encoding="application/x-tex">p_e</annotation></semantics></math>
= expected agreement by chance</p>
<div class="section level4">
<h4 id="agreement-interpretation-guidelines">Agreement Interpretation Guidelines<a class="anchor" aria-label="anchor" href="#agreement-interpretation-guidelines"></a>
</h4>
<table class="table">
<thead><tr class="header">
<th>Kappa Range</th>
<th>Agreement Level</th>
<th>Research Interpretation</th>
</tr></thead>
<tbody>
<tr class="odd">
<td>&lt; 0.00</td>
<td>Poor</td>
<td>Unacceptable for clinical use</td>
</tr>
<tr class="even">
<td>0.00-0.20</td>
<td>Slight</td>
<td>Needs substantial improvement</td>
</tr>
<tr class="odd">
<td>0.21-0.40</td>
<td>Fair</td>
<td>May be acceptable for some applications</td>
</tr>
<tr class="even">
<td>0.41-0.60</td>
<td>Moderate</td>
<td>Acceptable for many clinical uses</td>
</tr>
<tr class="odd">
<td>0.61-0.80</td>
<td>Good</td>
<td>Strong agreement for clinical practice</td>
</tr>
<tr class="even">
<td>0.81-1.00</td>
<td>Excellent</td>
<td>Ideal agreement level</td>
</tr>
</tbody>
</table>
</div>
</div>
<div class="section level3">
<h3 id="power-analysis-theory">Power Analysis Theory<a class="anchor" aria-label="anchor" href="#power-analysis-theory"></a>
</h3>
<div class="section level4">
<h4 id="sample-size-determinants">Sample Size Determinants<a class="anchor" aria-label="anchor" href="#sample-size-determinants"></a>
</h4>
<p>Sample size requirements depend on:</p>
<ol style="list-style-type: decimal">
<li>
<strong>Effect Size (κ₁ - κ₀)</strong>: Larger differences require
smaller samples</li>
<li>
<strong>Desired Power</strong>: Higher power requires larger
samples<br>
</li>
<li>
<strong>Significance Level (α)</strong>: Stricter levels require
larger samples</li>
<li>
<strong>Number of Categories</strong>: More categories generally
require larger samples</li>
<li>
<strong>Number of Raters</strong>: More raters can affect sample
size requirements</li>
<li>
<strong>Category Proportions</strong>: Unbalanced distributions may
require larger samples</li>
</ol>
</div>
<div class="section level4">
<h4 id="statistical-framework">Statistical Framework<a class="anchor" aria-label="anchor" href="#statistical-framework"></a>
</h4>
<p>The <code>kappasizepower</code> function uses the
<code>kappaSize</code> package implementation of power calculations for
different numbers of outcome categories:</p>
</div>
<div class="section level4">
<h4 id="binary-outcomes-2-categories">Binary Outcomes (2 categories)<a class="anchor" aria-label="anchor" href="#binary-outcomes-2-categories"></a>
</h4>
<p>Uses asymptotic variance estimates for binary kappa with finite
sample corrections.</p>
</div>
<div class="section level4">
<h4 id="multi-category-outcomes-3-5-categories">Multi-category Outcomes (3-5 categories)<a class="anchor" aria-label="anchor" href="#multi-category-outcomes-3-5-categories"></a>
</h4>
<p>Employs generalized kappa variance formulas accounting for: - Number
of categories and raters - Marginal probability distributions - Complex
covariance structures</p>
</div>
</div>
</div>
<div class="section level2">
<h2 id="function-parameters-and-usage">Function Parameters and Usage<a class="anchor" aria-label="anchor" href="#function-parameters-and-usage"></a>
</h2>
<div class="section level3">
<h3 id="basic-syntax">Basic Syntax<a class="anchor" aria-label="anchor" href="#basic-syntax"></a>
</h3>
<div class="sourceCode" id="cb1"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"2"</span>,           <span class="co"># Number of categories (2, 3, 4, or 5)</span></span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.40</span>,          <span class="co"># Null hypothesis kappa value</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.60</span>,          <span class="co"># Alternative hypothesis kappa value</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.30, 0.70"</span>,   <span class="co"># Category proportions</span></span>
<span>  raters <span class="op">=</span> <span class="st">"2"</span>,           <span class="co"># Number of raters (2-5)</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,           <span class="co"># Significance level</span></span>
<span>  power <span class="op">=</span> <span class="fl">0.80</span>            <span class="co"># Desired power</span></span>
<span><span class="op">)</span></span></code></pre></div>
</div>
<div class="section level3">
<h3 id="parameter-details">Parameter Details<a class="anchor" aria-label="anchor" href="#parameter-details"></a>
</h3>
<div class="section level4">
<h4 id="outcome-number-of-outcome-categories">
<code>outcome</code>: Number of Outcome Categories<a class="anchor" aria-label="anchor" href="#outcome-number-of-outcome-categories"></a>
</h4>
<ul>
<li>
<strong>Options</strong>: “2”, “3”, “4”, “5”</li>
<li>
<strong>Purpose</strong>: Determines which statistical model to
use</li>
<li>
<strong>Clinical Examples</strong>:
<ul>
<li>
<strong>2</strong>: Disease present/absent, positive/negative
test</li>
<li>
<strong>3</strong>: Mild/moderate/severe disease</li>
<li>
<strong>4</strong>: WHO grade 1-4, ECOG performance status</li>
<li>
<strong>5</strong>: Likert scales, comprehensive rating systems</li>
</ul>
</li>
</ul>
</div>
<div class="section level4">
<h4 id="kappa0-null-hypothesis-kappa">
<code>kappa0</code>: Null Hypothesis Kappa<a class="anchor" aria-label="anchor" href="#kappa0-null-hypothesis-kappa"></a>
</h4>
<ul>
<li>
<strong>Range</strong>: 0.01 to 0.99 (exclusive)</li>
<li>
<strong>Purpose</strong>: Current or baseline agreement level</li>
<li>
<strong>Sources</strong>: Literature review, pilot data, current
practice assessment</li>
</ul>
</div>
<div class="section level4">
<h4 id="kappa1-alternative-hypothesis-kappa">
<code>kappa1</code>: Alternative Hypothesis Kappa<a class="anchor" aria-label="anchor" href="#kappa1-alternative-hypothesis-kappa"></a>
</h4>
<ul>
<li>
<strong>Range</strong>: 0.01 to 0.99 (exclusive)</li>
<li>
<strong>Critical Requirement</strong>: <strong>Must be greater than
kappa0</strong>
</li>
<li>
<strong>Purpose</strong>: Target agreement level after
intervention/training</li>
<li>
<strong>Effect Size</strong>: κ₁ - κ₀ represents the improvement you
want to detect</li>
</ul>
</div>
<div class="section level4">
<h4 id="props-category-proportions">
<code>props</code>: Category Proportions<a class="anchor" aria-label="anchor" href="#props-category-proportions"></a>
</h4>
<ul>
<li>
<strong>Format</strong>: Comma-separated proportions that sum to
1.0</li>
<li>
<strong>Examples</strong>:
<ul>
<li>Binary: “0.25, 0.75” (25% disease prevalence)</li>
<li>Three-category: “0.20, 0.50, 0.30”</li>
</ul>
</li>
<li>
<strong>Sources</strong>: Registry data, literature, preliminary
studies</li>
</ul>
</div>
<div class="section level4">
<h4 id="raters-number-of-raters">
<code>raters</code>: Number of Raters<a class="anchor" aria-label="anchor" href="#raters-number-of-raters"></a>
</h4>
<ul>
<li>
<strong>Options</strong>: “2”, “3”, “4”, “5”</li>
<li>
<strong>Impact</strong>: More raters can improve precision but
increase complexity</li>
<li>
<strong>Practical considerations</strong>: Availability, cost,
training requirements</li>
</ul>
</div>
<div class="section level4">
<h4 id="alpha-significance-level">
<code>alpha</code>: Significance Level<a class="anchor" aria-label="anchor" href="#alpha-significance-level"></a>
</h4>
<ul>
<li>
<strong>Common values</strong>: 0.05 (5%), 0.01 (1%)</li>
<li>
<strong>Impact</strong>: Lower alpha requires larger sample
sizes</li>
<li>
<strong>Selection</strong>: Based on field standards and consequence
of errors</li>
</ul>
</div>
<div class="section level4">
<h4 id="power-desired-power">
<code>power</code>: Desired Power<a class="anchor" aria-label="anchor" href="#power-desired-power"></a>
</h4>
<ul>
<li>
<strong>Range</strong>: 0.01 to 0.99, typically ≥ 0.80</li>
<li>
<strong>Common values</strong>: 0.80 (80%), 0.90 (90%)</li>
<li>
<strong>Impact</strong>: Higher power requires larger sample
sizes</li>
<li>
<strong>Minimum</strong>: Should be at least 0.50 for meaningful
analysis</li>
</ul>
</div>
</div>
</div>
<div class="section level2">
<h2 id="clinical-applications-and-examples">Clinical Applications and Examples<a class="anchor" aria-label="anchor" href="#clinical-applications-and-examples"></a>
</h2>
<div class="section level3">
<h3 id="medical-diagnosis-studies">Medical Diagnosis Studies<a class="anchor" aria-label="anchor" href="#medical-diagnosis-studies"></a>
</h3>
<div class="section level4">
<h4 id="example-1-emergency-department-pneumonia-detection">Example 1: Emergency Department Pneumonia Detection<a class="anchor" aria-label="anchor" href="#example-1-emergency-department-pneumonia-detection"></a>
</h4>
<p><strong>Scenario</strong>: Emergency physicians want to validate that
training improves chest X-ray agreement for pneumonia detection.</p>
<div class="sourceCode" id="cb2"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Emergency department pneumonia training validation</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"2"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.50</span>,          <span class="co"># Current fair agreement</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.75</span>,          <span class="co"># Target good agreement post-training</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.25, 0.75"</span>,   <span class="co"># 25% pneumonia prevalence</span></span>
<span>  raters <span class="op">=</span> <span class="st">"2"</span>,           <span class="co"># Two emergency physicians</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.80</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>Clinical Context</strong>: - Training programs require
validation of effectiveness - Patient safety depends on reliable
pneumonia detection - Effect size of 0.25 (0.75 - 0.50) represents
meaningful improvement</p>
</div>
<div class="section level4">
<h4 id="example-2-mammography-screening-enhancement">Example 2: Mammography Screening Enhancement<a class="anchor" aria-label="anchor" href="#example-2-mammography-screening-enhancement"></a>
</h4>
<p><strong>Scenario</strong>: Radiologists implementing new BI-RADS
standardization want to demonstrate improved agreement.</p>
<div class="sourceCode" id="cb3"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Mammography screening standardization study</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"2"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.60</span>,          <span class="co"># Current good agreement</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.80</span>,          <span class="co"># Target excellent agreement</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.12, 0.88"</span>,   <span class="co"># 12% positive findings (BI-RADS 4-5)</span></span>
<span>  raters <span class="op">=</span> <span class="st">"2"</span>,           <span class="co"># Two radiologists</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.85</span>            <span class="co"># Higher power for screening validation</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>Clinical Context</strong>: - Screening programs require high
agreement levels - Effect size of 0.20 represents substantial
improvement - Higher power (85%) provides stronger evidence</p>
</div>
</div>
<div class="section level3">
<h3 id="multi-category-medical-assessments">Multi-Category Medical Assessments<a class="anchor" aria-label="anchor" href="#multi-category-medical-assessments"></a>
</h3>
<div class="section level4">
<h4 id="example-3-heart-failure-severity-staging">Example 3: Heart Failure Severity Staging<a class="anchor" aria-label="anchor" href="#example-3-heart-failure-severity-staging"></a>
</h4>
<p><strong>Scenario</strong>: Cardiologists validating new
echocardiographic staging criteria.</p>
<div class="sourceCode" id="cb4"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Heart failure staging validation study</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"3"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.55</span>,          <span class="co"># Current moderate agreement</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.75</span>,          <span class="co"># Target good agreement</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.20, 0.50, 0.30"</span>,  <span class="co"># Mild, Moderate, Severe</span></span>
<span>  raters <span class="op">=</span> <span class="st">"2"</span>,           <span class="co"># Two cardiologists</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.80</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>Clinical Context</strong>: - Staging affects treatment
decisions - Standardization improves patient outcomes - Multi-category
assessment adds complexity</p>
</div>
<div class="section level4">
<h4 id="example-4-burn-severity-grading-protocol">Example 4: Burn Severity Grading Protocol<a class="anchor" aria-label="anchor" href="#example-4-burn-severity-grading-protocol"></a>
</h4>
<p><strong>Scenario</strong>: Emergency physicians implementing
standardized burn severity assessment.</p>
<div class="sourceCode" id="cb5"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Burn severity grading standardization</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"3"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.60</span>,          <span class="co"># Current good agreement</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.85</span>,          <span class="co"># Target excellent agreement</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.40, 0.35, 0.25"</span>,  <span class="co"># First, Second, Third degree</span></span>
<span>  raters <span class="op">=</span> <span class="st">"3"</span>,           <span class="co"># Three emergency physicians</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.80</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>Clinical Context</strong>: - Burn severity affects triage
decisions - Large effect size (0.25) represents major improvement -
Multiple raters increase reliability</p>
</div>
</div>
<div class="section level3">
<h3 id="complex-multi-category-studies">Complex Multi-Category Studies<a class="anchor" aria-label="anchor" href="#complex-multi-category-studies"></a>
</h3>
<div class="section level4">
<h4 id="example-5-tumor-grading-standardization">Example 5: Tumor Grading Standardization<a class="anchor" aria-label="anchor" href="#example-5-tumor-grading-standardization"></a>
</h4>
<p><strong>Scenario</strong>: Pathologists implementing standardized
tumor grading criteria.</p>
<div class="sourceCode" id="cb6"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Tumor grading standardization study</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"4"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.60</span>,          <span class="co"># Current good agreement</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.80</span>,          <span class="co"># Target very good agreement</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.15, 0.25, 0.35, 0.25"</span>,  <span class="co"># Grade 1, 2, 3, 4</span></span>
<span>  raters <span class="op">=</span> <span class="st">"3"</span>,           <span class="co"># Three pathologists</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.80</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>Clinical Context</strong>: - Tumor grading affects treatment
decisions - Standardization reduces inter-institutional variability -
Four categories require careful power analysis</p>
</div>
<div class="section level4">
<h4 id="example-6-cognitive-assessment-tool-validation">Example 6: Cognitive Assessment Tool Validation<a class="anchor" aria-label="anchor" href="#example-6-cognitive-assessment-tool-validation"></a>
</h4>
<p><strong>Scenario</strong>: Neuropsychologists validating structured
cognitive assessment protocol.</p>
<div class="sourceCode" id="cb7"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Cognitive assessment tool validation</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"4"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.55</span>,          <span class="co"># Current moderate agreement</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.75</span>,          <span class="co"># Target good agreement</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.20, 0.30, 0.30, 0.20"</span>,  <span class="co"># Normal, MCI, Mild, Moderate+ dementia</span></span>
<span>  raters <span class="op">=</span> <span class="st">"2"</span>,           <span class="co"># Two neuropsychologists</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.80</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>Clinical Context</strong>: - Cognitive assessment affects
care planning - Structured protocols improve consistency - Effect size
of 0.20 represents meaningful improvement</p>
</div>
</div>
<div class="section level3">
<h3 id="high-precision-research-applications">High-Precision Research Applications<a class="anchor" aria-label="anchor" href="#high-precision-research-applications"></a>
</h3>
<div class="section level4">
<h4 id="example-7-surgical-complication-grading">Example 7: Surgical Complication Grading<a class="anchor" aria-label="anchor" href="#example-7-surgical-complication-grading"></a>
</h4>
<p><strong>Scenario</strong>: Surgeons implementing standardized
Clavien-Dindo classification.</p>
<div class="sourceCode" id="cb8"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Surgical complication grading validation</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"4"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.65</span>,          <span class="co"># Current good agreement</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.85</span>,          <span class="co"># Target excellent agreement</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.40, 0.30, 0.20, 0.10"</span>,  <span class="co"># None, Grade I, II, III+</span></span>
<span>  raters <span class="op">=</span> <span class="st">"3"</span>,           <span class="co"># Three surgeons</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.01</span>,           <span class="co"># Strict significance level</span></span>
<span>  power <span class="op">=</span> <span class="fl">0.90</span>            <span class="co"># High power requirement</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>Clinical Context</strong>: - Surgical outcomes require high
precision - Strict alpha (0.01) and high power (90%) for rigorous
validation - Large effect size (0.20) represents substantial
improvement</p>
</div>
<div class="section level4">
<h4 id="example-8-biomarker-expression-assessment">Example 8: Biomarker Expression Assessment<a class="anchor" aria-label="anchor" href="#example-8-biomarker-expression-assessment"></a>
</h4>
<p><strong>Scenario</strong>: Pathologists standardizing
immunohistochemical scoring.</p>
<div class="sourceCode" id="cb9"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Biomarker expression standardization</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"3"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.70</span>,          <span class="co"># Current good agreement</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.90</span>,          <span class="co"># Target excellent agreement</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.30, 0.45, 0.25"</span>,  <span class="co"># Low, Moderate, High expression</span></span>
<span>  raters <span class="op">=</span> <span class="st">"2"</span>,           <span class="co"># Two pathologists</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.01</span>,           <span class="co"># Strict significance level</span></span>
<span>  power <span class="op">=</span> <span class="fl">0.90</span>            <span class="co"># High power requirement</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>Clinical Context</strong>: - Biomarker scoring affects
treatment decisions - Research applications require high precision -
Large effect size (0.20) with strict criteria</p>
</div>
</div>
</div>
<div class="section level2">
<h2 id="advanced-applications">Advanced Applications<a class="anchor" aria-label="anchor" href="#advanced-applications"></a>
</h2>
<div class="section level3">
<h3 id="effect-size-considerations">Effect Size Considerations<a class="anchor" aria-label="anchor" href="#effect-size-considerations"></a>
</h3>
<div class="section level4">
<h4 id="small-effect-sizes-κ₁---κ₀-0-20">Small Effect Sizes (κ₁ - κ₀ &lt; 0.20)<a class="anchor" aria-label="anchor" href="#small-effect-sizes-%CE%BA%E2%82%81---%CE%BA%E2%82%80-0-20"></a>
</h4>
<p>Require large sample sizes but may be clinically meaningful:</p>
<div class="sourceCode" id="cb10"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Small but clinically significant improvement</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"2"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.70</span>,          <span class="co"># Already good agreement</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.80</span>,          <span class="co"># Modest improvement</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.50, 0.50"</span>,   <span class="co"># Balanced categories</span></span>
<span>  raters <span class="op">=</span> <span class="st">"2"</span>,</span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.80</span></span>
<span><span class="op">)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="large-effect-sizes-κ₁---κ₀-0-30">Large Effect Sizes (κ₁ - κ₀ &gt; 0.30)<a class="anchor" aria-label="anchor" href="#large-effect-sizes-%CE%BA%E2%82%81---%CE%BA%E2%82%80-0-30"></a>
</h4>
<p>Require smaller sample sizes, easier to detect:</p>
<div class="sourceCode" id="cb11"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Large improvement from training</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"2"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.30</span>,          <span class="co"># Poor baseline agreement</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.70</span>,          <span class="co"># Good post-training agreement</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.25, 0.75"</span>,</span>
<span>  raters <span class="op">=</span> <span class="st">"2"</span>,</span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.80</span></span>
<span><span class="op">)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="dealing-with-unbalanced-proportions">Dealing with Unbalanced Proportions<a class="anchor" aria-label="anchor" href="#dealing-with-unbalanced-proportions"></a>
</h3>
<div class="section level4">
<h4 id="rare-event-studies">Rare Event Studies<a class="anchor" aria-label="anchor" href="#rare-event-studies"></a>
</h4>
<div class="sourceCode" id="cb12"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Rare disease diagnosis agreement</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"2"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.60</span>,</span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.80</span>,</span>
<span>  props <span class="op">=</span> <span class="st">"0.05, 0.95"</span>,   <span class="co"># 5% rare disease prevalence</span></span>
<span>  raters <span class="op">=</span> <span class="st">"3"</span>,</span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.80</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>Considerations for Unbalanced Data</strong>: - May require
larger sample sizes - Consider stratified analysis approaches - Validate
results with simulation studies</p>
</div>
</div>
<div class="section level3">
<h3 id="high-power-study-designs">High-Power Study Designs<a class="anchor" aria-label="anchor" href="#high-power-study-designs"></a>
</h3>
<div class="section level4">
<h4 id="research-validation-studies">Research Validation Studies<a class="anchor" aria-label="anchor" href="#research-validation-studies"></a>
</h4>
<div class="sourceCode" id="cb13"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># High-power research validation</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"5"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.50</span>,</span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.70</span>,</span>
<span>  props <span class="op">=</span> <span class="st">"0.10, 0.20, 0.35, 0.25, 0.10"</span>,</span>
<span>  raters <span class="op">=</span> <span class="st">"4"</span>,</span>
<span>  alpha <span class="op">=</span> <span class="fl">0.01</span>,           <span class="co"># Strict significance</span></span>
<span>  power <span class="op">=</span> <span class="fl">0.95</span>            <span class="co"># Very high power</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>High-Power Considerations</strong>: - Necessary for
definitive validation studies - Required for regulatory submissions -
Increases sample size requirements substantially</p>
</div>
</div>
<div class="section level3">
<h3 id="multi-center-study-planning">Multi-Center Study Planning<a class="anchor" aria-label="anchor" href="#multi-center-study-planning"></a>
</h3>
<div class="section level4">
<h4 id="coordinated-research-networks">Coordinated Research Networks<a class="anchor" aria-label="anchor" href="#coordinated-research-networks"></a>
</h4>
<div class="sourceCode" id="cb14"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Multi-center standardization study</span></span>
<span><span class="va">result</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/kappaSizePower.html">kappaSizePower</a></span><span class="op">(</span></span>
<span>  outcome <span class="op">=</span> <span class="st">"4"</span>,</span>
<span>  kappa0 <span class="op">=</span> <span class="fl">0.55</span>,          <span class="co"># Current multi-center variability</span></span>
<span>  kappa1 <span class="op">=</span> <span class="fl">0.75</span>,          <span class="co"># Target standardized agreement</span></span>
<span>  props <span class="op">=</span> <span class="st">"0.25, 0.30, 0.25, 0.20"</span>,</span>
<span>  raters <span class="op">=</span> <span class="st">"3"</span>,           <span class="co"># Representative raters per site</span></span>
<span>  alpha <span class="op">=</span> <span class="fl">0.05</span>,</span>
<span>  power <span class="op">=</span> <span class="fl">0.85</span>            <span class="co"># Higher power for multi-center</span></span>
<span><span class="op">)</span></span></code></pre></div>
<p><strong>Multi-Center Considerations</strong>: - Account for
between-site variability - Consider hierarchical study designs - Plan
for adequate power at each site</p>
</div>
</div>
</div>
<div class="section level2">
<h2 id="best-practices-and-guidelines">Best Practices and Guidelines<a class="anchor" aria-label="anchor" href="#best-practices-and-guidelines"></a>
</h2>
<div class="section level3">
<h3 id="study-design-considerations">Study Design Considerations<a class="anchor" aria-label="anchor" href="#study-design-considerations"></a>
</h3>
<div class="section level4">
<h4 id="realistic-effect-size-setting">1. <strong>Realistic Effect Size Setting</strong><a class="anchor" aria-label="anchor" href="#realistic-effect-size-setting"></a>
</h4>
<ul>
<li>Base κ₀ on literature review or pilot data</li>
<li>Set κ₁ to represent clinically meaningful improvement</li>
<li>Consider that improvement often decreases in real-world
settings</li>
</ul>
</div>
<div class="section level4">
<h4 id="proportion-estimation">2. <strong>Proportion Estimation</strong><a class="anchor" aria-label="anchor" href="#proportion-estimation"></a>
</h4>
<ul>
<li>Use registry data or large databases when available</li>
<li>Consider temporal and geographical variations</li>
<li>Account for selection bias in study populations</li>
</ul>
</div>
<div class="section level4">
<h4 id="power-and-alpha-selection">3. <strong>Power and Alpha Selection</strong><a class="anchor" aria-label="anchor" href="#power-and-alpha-selection"></a>
</h4>
<p><strong>Standard Approaches</strong>: - <strong>α = 0.05, Power =
0.80</strong>: Most clinical studies - <strong>α = 0.01, Power =
0.90</strong>: High-stakes validation studies - <strong>α = 0.05, Power
= 0.85</strong>: Regulatory submissions</p>
</div>
<div class="section level4">
<h4 id="rater-selection-and-training">4. <strong>Rater Selection and Training</strong><a class="anchor" aria-label="anchor" href="#rater-selection-and-training"></a>
</h4>
<ul>
<li>
<strong>Training</strong>: Ensure consistent training across
raters</li>
<li>
<strong>Experience</strong>: Balance expertise with
availability</li>
<li>
<strong>Independence</strong>: Maintain rater independence during
assessment</li>
<li>
<strong>Calibration</strong>: Consider calibration exercises</li>
</ul>
</div>
</div>
<div class="section level3">
<h3 id="common-pitfalls-and-solutions">Common Pitfalls and Solutions<a class="anchor" aria-label="anchor" href="#common-pitfalls-and-solutions"></a>
</h3>
<div class="section level4">
<h4 id="unrealistic-effect-size-expectations">1. <strong>Unrealistic Effect Size Expectations</strong><a class="anchor" aria-label="anchor" href="#unrealistic-effect-size-expectations"></a>
</h4>
<p><strong>Problem</strong>: Setting κ₁ too high based on ideal
conditions</p>
<p><strong>Solution</strong>: - Review literature for realistic
agreement levels - Conduct pilot studies under actual conditions -
Account for implementation challenges</p>
</div>
<div class="section level4">
<h4 id="ignoring-practical-constraints">2. <strong>Ignoring Practical Constraints</strong><a class="anchor" aria-label="anchor" href="#ignoring-practical-constraints"></a>
</h4>
<p><strong>Problem</strong>: Sample size calculations that exceed
feasible recruitment</p>
<p><strong>Solution</strong>: - Consider feasibility during planning -
Explore alternative study designs - Plan for adaptive or sequential
designs</p>
</div>
<div class="section level4">
<h4 id="inadequate-baseline-assessment">3. <strong>Inadequate Baseline Assessment</strong><a class="anchor" aria-label="anchor" href="#inadequate-baseline-assessment"></a>
</h4>
<p><strong>Problem</strong>: Poor κ₀ estimation leading to underpowered
studies</p>
<p><strong>Solution</strong>: - Conduct thorough baseline assessment -
Use multiple data sources for κ₀ estimation - Consider sensitivity
analyses</p>
</div>
<div class="section level4">
<h4 id="overlooking-implementation-complexity">4. <strong>Overlooking Implementation Complexity</strong><a class="anchor" aria-label="anchor" href="#overlooking-implementation-complexity"></a>
</h4>
<p><strong>Problem</strong>: Not accounting for real-world
implementation challenges</p>
<p><strong>Solution</strong>: - Plan for training and calibration time -
Account for rater availability and scheduling - Consider quality control
procedures</p>
</div>
</div>
<div class="section level3">
<h3 id="quality-assurance-framework">Quality Assurance Framework<a class="anchor" aria-label="anchor" href="#quality-assurance-framework"></a>
</h3>
<div class="section level4">
<h4 id="pre-study-planning-checklist">Pre-study Planning Checklist<a class="anchor" aria-label="anchor" href="#pre-study-planning-checklist"></a>
</h4>
<ul class="task-list">
<li><label><input type="checkbox">Literature review completed for
realistic κ₀ and κ₁ values</label></li>
<li><label><input type="checkbox">Proportion estimates obtained from
reliable sources</label></li>
<li><label><input type="checkbox">Power analysis conducted with
multiple scenarios</label></li>
<li><label><input type="checkbox">Feasibility assessment
completed</label></li>
<li><label><input type="checkbox">Rater training protocol
established</label></li>
<li><label><input type="checkbox">Quality control procedures
defined</label></li>
</ul>
</div>
<div class="section level4">
<h4 id="during-study-monitoring">During-study Monitoring<a class="anchor" aria-label="anchor" href="#during-study-monitoring"></a>
</h4>
<ul class="task-list">
<li><label><input type="checkbox">Interim agreement assessments
conducted</label></li>
<li><label><input type="checkbox">Rater consistency
monitored</label></li>
<li><label><input type="checkbox">Protocol adherence
documented</label></li>
<li><label><input type="checkbox">Sample size adequacy
reassessed</label></li>
</ul>
</div>
<div class="section level4">
<h4 id="post-study-validation">Post-study Validation<a class="anchor" aria-label="anchor" href="#post-study-validation"></a>
</h4>
<ul class="task-list">
<li><label><input type="checkbox">Achieved agreement levels compared
to predictions</label></li>
<li><label><input type="checkbox">Power analysis assumptions
validated</label></li>
<li><label><input type="checkbox">Lessons learned documented for
future studies</label></li>
</ul>
</div>
</div>
</div>
<div class="section level2">
<h2 id="interpretation-of-results">Interpretation of Results<a class="anchor" aria-label="anchor" href="#interpretation-of-results"></a>
</h2>
<div class="section level3">
<h3 id="understanding-power-analysis-output">Understanding Power Analysis Output<a class="anchor" aria-label="anchor" href="#understanding-power-analysis-output"></a>
</h3>
<p>The <code>kappasizepower</code> function provides:</p>
<ol style="list-style-type: decimal">
<li>
<strong>Required Sample Size</strong>: Number of subjects
needed</li>
<li>
<strong>Study Design Summary</strong>: Comprehensive explanation of
parameters and context</li>
</ol>
<div class="section level4">
<h4 id="sample-size-interpretation">Sample Size Interpretation<a class="anchor" aria-label="anchor" href="#sample-size-interpretation"></a>
</h4>
<p><strong>Key Considerations</strong>: - Sample size refers to number
of subjects rated by all raters - Consider dropout rates and missing
data - Plan for quality control assessments</p>
</div>
<div class="section level4">
<h4 id="clinical-decision-making">Clinical Decision Making<a class="anchor" aria-label="anchor" href="#clinical-decision-making"></a>
</h4>
<p>Use results to: - <strong>Justify study feasibility</strong> in grant
applications - <strong>Set recruitment targets</strong> for multi-center
studies - <strong>Inform resource planning</strong> for training and
implementation - <strong>Support protocol development</strong></p>
</div>
</div>
<div class="section level3">
<h3 id="reporting-guidelines">Reporting Guidelines<a class="anchor" aria-label="anchor" href="#reporting-guidelines"></a>
</h3>
<div class="section level4">
<h4 id="in-grant-applications">In Grant Applications<a class="anchor" aria-label="anchor" href="#in-grant-applications"></a>
</h4>
<p>“Power analysis using kappasizepower indicated that N subjects are
required to detect an improvement in inter-rater agreement from κ₀=X to
κ₁=Y with 80% power at the 5% significance level.”</p>
</div>
<div class="section level4">
<h4 id="in-study-protocols">In Study Protocols<a class="anchor" aria-label="anchor" href="#in-study-protocols"></a>
</h4>
<p>Detail the power analysis assumptions including: - Baseline agreement
estimates and sources - Target agreement levels and justification -
Effect size rationale - Power and alpha selection rationale</p>
</div>
<div class="section level4">
<h4 id="in-manuscripts">In Manuscripts<a class="anchor" aria-label="anchor" href="#in-manuscripts"></a>
</h4>
<p>Report both the power analysis and achieved results: - Compare
observed agreement to predicted levels - Discuss any discrepancies
between planned and achieved parameters - Address implications for study
conclusions</p>
</div>
</div>
</div>
<div class="section level2">
<h2 id="troubleshooting-common-issues">Troubleshooting Common Issues<a class="anchor" aria-label="anchor" href="#troubleshooting-common-issues"></a>
</h2>
<div class="section level3">
<h3 id="error-messages-and-solutions">Error Messages and Solutions<a class="anchor" aria-label="anchor" href="#error-messages-and-solutions"></a>
</h3>
<div class="section level4">
<h4 id="kappa1-must-be-greater-than-kappa0">“kappa1 must be greater than kappa0”<a class="anchor" aria-label="anchor" href="#kappa1-must-be-greater-than-kappa0"></a>
</h4>
<p><strong>Cause</strong>: Alternative hypothesis agreement is not
better than null hypothesis</p>
<p><strong>Solution</strong>:</p>
<div class="sourceCode" id="cb15"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb15-1"><a href="#cb15-1" tabindex="-1"></a><span class="co"># Incorrect</span></span>
<span id="cb15-2"><a href="#cb15-2" tabindex="-1"></a>kappa0 <span class="ot">=</span> <span class="fl">0.70</span>, kappa1 <span class="ot">=</span> <span class="fl">0.60</span>  <span class="co"># kappa1 &lt; kappa0</span></span>
<span id="cb15-3"><a href="#cb15-3" tabindex="-1"></a></span>
<span id="cb15-4"><a href="#cb15-4" tabindex="-1"></a><span class="co"># Correct</span></span>
<span id="cb15-5"><a href="#cb15-5" tabindex="-1"></a>kappa0 <span class="ot">=</span> <span class="fl">0.60</span>, kappa1 <span class="ot">=</span> <span class="fl">0.70</span>  <span class="co"># kappa1 &gt; kappa0</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="proportions-must-sum-to-1">“Proportions must sum to 1”<a class="anchor" aria-label="anchor" href="#proportions-must-sum-to-1"></a>
</h4>
<p><strong>Cause</strong>: Category proportions don’t sum to exactly
1.0</p>
<p><strong>Solution</strong>: Adjust proportions or use normalized
values</p>
<div class="sourceCode" id="cb16"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Incorrect</span></span>
<span><span class="va">props</span> <span class="op">=</span> <span class="st">"0.25, 0.80"</span>  <span class="co"># Sums to 1.05</span></span>
<span></span>
<span><span class="co"># Correct</span></span>
<span><span class="va">props</span> <span class="op">=</span> <span class="st">"0.24, 0.76"</span>  <span class="co"># Sums to 1.00</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="power-should-be-at-least-0-5-for-meaningful-analysis">“Power should be at least 0.5 for meaningful analysis”<a class="anchor" aria-label="anchor" href="#power-should-be-at-least-0-5-for-meaningful-analysis"></a>
</h4>
<p><strong>Cause</strong>: Power set too low for reasonable
detection</p>
<p><strong>Solution</strong>: Increase power to at least 50%, typically
80%</p>
<div class="sourceCode" id="cb17"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="co"># Problematic</span></span>
<span><span class="va">power</span> <span class="op">=</span> <span class="fl">0.30</span>  <span class="co"># Too low</span></span>
<span></span>
<span><span class="co"># Recommended</span></span>
<span><span class="va">power</span> <span class="op">=</span> <span class="fl">0.80</span>  <span class="co"># Standard minimum</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="kappasize-package-not-installed">“kappaSize package not installed”<a class="anchor" aria-label="anchor" href="#kappasize-package-not-installed"></a>
</h4>
<p><strong>Cause</strong>: Required dependency not available</p>
<p><strong>Solution</strong>: Install the kappaSize package</p>
<div class="sourceCode" id="cb18"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="https://rdrr.io/r/utils/install.packages.html" class="external-link">install.packages</a></span><span class="op">(</span><span class="st">"kappaSize"</span><span class="op">)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="computational-issues">Computational Issues<a class="anchor" aria-label="anchor" href="#computational-issues"></a>
</h3>
<div class="section level4">
<h4 id="very-large-sample-size-requirements">Very Large Sample Size Requirements<a class="anchor" aria-label="anchor" href="#very-large-sample-size-requirements"></a>
</h4>
<p>When sample sizes exceed feasible limits:</p>
<p><strong>Solutions</strong>: - Reduce effect size expectations
(smaller κ₁ - κ₀) - Accept lower power (minimum 80%) - Consider
multi-stage or adaptive designs - Explore alternative study
approaches</p>
</div>
<div class="section level4">
<h4 id="small-effect-sizes">Small Effect Sizes<a class="anchor" aria-label="anchor" href="#small-effect-sizes"></a>
</h4>
<p>For very small effect sizes (κ₁ - κ₀ &lt; 0.10):</p>
<p><strong>Considerations</strong>: - Ensure clinical meaningfulness of
small improvements - Consider cost-benefit of large sample requirements
- Explore whether the improvement justifies the study</p>
</div>
<div class="section level4">
<h4 id="complex-multi-rater-scenarios">Complex Multi-rater Scenarios<a class="anchor" aria-label="anchor" href="#complex-multi-rater-scenarios"></a>
</h4>
<p>With 4-5 raters and 4-5 categories:</p>
<p><strong>Solutions</strong>: - Ensure computational stability with
adequate samples - Consider phased implementation approaches - Validate
with simulation studies</p>
</div>
</div>
</div>
<div class="section level2">
<h2 id="future-directions-and-related-tools">Future Directions and Related Tools<a class="anchor" aria-label="anchor" href="#future-directions-and-related-tools"></a>
</h2>
<div class="section level3">
<h3 id="complementary-functions">Complementary Functions<a class="anchor" aria-label="anchor" href="#complementary-functions"></a>
</h3>
<p>The <code>kappasizepower</code> function works alongside:</p>
<ul>
<li>
<strong><code>kappasizefixedn</code></strong>: For fixed sample size
power analysis</li>
<li>
<strong>Other agreement functions</strong>: For post-hoc agreement
assessment</li>
<li>
<strong>Sample size calculators</strong>: For comprehensive study
planning</li>
</ul>
</div>
<div class="section level3">
<h3 id="advanced-methods">Advanced Methods<a class="anchor" aria-label="anchor" href="#advanced-methods"></a>
</h3>
<p>For specialized scenarios, consider:</p>
<ul>
<li>
<strong>Weighted kappa</strong>: For ordinal categories with
meaningful ordering</li>
<li>
<strong>Multilevel models</strong>: For hierarchical data
structures</li>
<li>
<strong>Bayesian approaches</strong>: For incorporating prior
information</li>
<li>
<strong>Sequential designs</strong>: For adaptive sample size
modification</li>
</ul>
</div>
<div class="section level3">
<h3 id="software-integration">Software Integration<a class="anchor" aria-label="anchor" href="#software-integration"></a>
</h3>
<p>The function integrates well with:</p>
<ul>
<li>
<strong>jamovi</strong>: User-friendly interface for clinical
researchers</li>
<li>
<strong>R workflows</strong>: Programmable analysis pipelines</li>
<li>
<strong>Reproducible research</strong>: RMarkdown and Quarto
integration</li>
</ul>
</div>
</div>
<div class="section level2">
<h2 id="summary">Summary<a class="anchor" aria-label="anchor" href="#summary"></a>
</h2>
<p>The <code>kappasizepower</code> function provides essential power
analysis capabilities for inter-rater agreement studies. Key
takeaways:</p>
<ol style="list-style-type: decimal">
<li>
<strong>Use for prospective study planning</strong> requiring
specific power levels</li>
<li>
<strong>Ensures adequate sample sizes</strong> for detecting
meaningful agreement improvements</li>
<li>
<strong>Supports 2-5 categories</strong> and 2-5 raters with
comprehensive validation</li>
<li>
<strong>Requires κ₁ &gt; κ₀</strong> for valid power analysis</li>
<li>
<strong>Integrates with comprehensive research planning</strong>
workflows</li>
</ol>
<p>By understanding and properly applying this tool, researchers can
design adequately powered studies to validate inter-rater agreement
improvements, supporting evidence-based advances in clinical practice
and research methodology.</p>
</div>
<div class="section level2">
<h2 id="references">References<a class="anchor" aria-label="anchor" href="#references"></a>
</h2>
<ol style="list-style-type: decimal">
<li><p>Cohen, J. (1960). A coefficient of agreement for nominal scales.
Educational and Psychological Measurement, 20(1), 37-46.</p></li>
<li><p>Fleiss, J. L., Levin, B., &amp; Paik, M. C. (2003). Statistical
methods for rates and proportions. John Wiley &amp; Sons.</p></li>
<li><p>Gwet, K. L. (2014). Handbook of inter-rater reliability: The
definitive guide to measuring the extent of agreement among raters.
Advanced Analytics, LLC.</p></li>
<li><p>Landis, J. R., &amp; Koch, G. G. (1977). The measurement of
observer agreement for categorical data. Biometrics, 33(1),
159-174.</p></li>
<li><p>Shoukri, M. M. (2011). Measures of interobserver agreement and
reliability. Chapman and Hall/CRC.</p></li>
</ol>
<hr>
<p><em>This vignette was generated using the ClinicoPath R package. For
more information, visit the <a href="https://github.com/sbalci/ClinicoPathJamoviModule" class="external-link">ClinicoPath
GitHub repository</a>.</em></p>
</div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="pkgdown-footer-left">
  <p>Developed by Serdar Balci.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.1.3.</p>
</div>

    </footer>
</div>





  </body>
</html>
